Ibere Pharmaceuticals OverviewIbere Pharmaceuticals Other Income Expense Net
Other Income/Expense Net for IBER.
Quarterly Other Income/Expense
$1.02M
↓ 49.91% YoY
As of Sep 30, 2022
Annual Other Income/Expense (TTM)
$7.22M
Trailing 12 months ending Sep 30, 2022